Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina2024, 60, 243.
Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina 2024, 60, 243.
Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina2024, 60, 243.
Kawasaki, R. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan? Medicina 2024, 60, 243.
Abstract
In conclusion, this review highlights the challenges in the current screening pathway and the potential for AI, particularly LLM, to revolutionize DR screening in Japan. The future direction will depend on leadership from ophthalmologists and stakeholders to address long-standing challenges in DR screening so that all people have access to accessible and effective screening.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
